Primary Site >> Colorectal Cancer
Gene >> FLT3LG
| 1. | |||||||||||
| Journal: | J Clin Oncol. 2000 Dec 1;18(23):3883-93. | ||||||||||
| Title: | Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. | ||||||||||
| Author: | Morse, M A|Nair, S|Fernandez-Casal, M|Deng, Y|St Peter, M|Williams, R|Hobeika, A|Mosca, P|Clay, T|Cumming, R I|Fisher, E|Clavien, P|Proia, A D|Niedzwiecki, D|Caron, D|Lyerly, H K | ||||||||||
| PMID: | 11099317 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2007 Oct;56(10):1605-13. Epub 2007 Mar 15. | ||||||||||
| Title: | Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU. | ||||||||||
| Author: | Hou, Sheng|Kou, Geng|Fan, Xiaoqiang|Wang, Hao|Qian, Weizhu|Zhang, Dapeng|Li, Bohua|Dai, Jianxin|Zhao, Jian|Ma, Jing|Li, Jing|Lin, Birong|Wu, Mengchao|Guo, Yajun | ||||||||||
| PMID: | 17361437 | ||||||||||
| 3. | |||||||||||
| Journal: | J Immunol. 2017 Sep 1;199(5):1933-1941. | ||||||||||
| Title: | Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. | ||||||||||
| Author: | Hope, Chelsea|Emmerich, Philip B|Papadas, Athanasios|Pagenkopf, Adam|Matkowskyj, Kristina A|Van De Hey, Dana R|Payne, Susan N|Clipson, Linda|Callander, Natalie S|Hematti, Peiman|Miyamoto, Shigeki|Johnson, Michael G|Deming, Dustin A|Asimakopoulos, Fotis | ||||||||||
| PMID: | 28754680 | ||||||||||
| 4. | |||||||||||
| Journal: | Clin Epidemiol. 2017 Oct 31;9:517-526. | ||||||||||
| Title: | Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer. | ||||||||||
| Author: | Chen, Hongda|Qian, Jing|Werner, Simone|Cuk, Katarina|Knebel, Phillip|Brenner, Hermann | ||||||||||
| PMID: | 29184444 | ||||||||||
| 5. | |||||||||||
| Journal: | Br J Cancer. 2018 May;118(10):1322-1328. | ||||||||||
| Title: | Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer. | ||||||||||
| Author: | Kalanxhi, Erta|Meltzer, Sebastian|Schou, Jakob Vasehus|Larsen, Finn Ole|Dueland, Svein|Flatmark, Kjersti|Jensen, Benny Vittrup|Hole, Knut Hakon|Seierstad, Therese|Redalen, Kathrine Roe|Nielsen, Dorte Lisbet|Ree, Anne Hansen | ||||||||||
| PMID: | 29695770 | ||||||||||